A surprising link between the immune system and brain behavior is emerging, as new research reveals how a single immune ...

With a market cap of $102.7 billion, Bristol-Myers Squibb Company (BMY) is a leading global biopharmaceutical company ...

Researchers have successfully developed nerve grafts, currently being trialed as a treatment for Parkinson’s disease, that ...

The U.S. Food and Drug Administration has approved a prefilled syringe version of Netherlands-based Argenx SE's blockbuster ...

Mark T. Esser, a pharmaceutical researcher and executive, brings scientific expertise and leadership experience to his new ...

The FDA is phasing out an animal testing requirement for monoclonal antibody therapies in favor of testing drugs on “lab-grown human ‘organoids.'" ...

Once thought improbable, in vitro human models are demonstrating technological prowess in a growing range of applications.

The Hidradenitis Suppurativa Genetics Consortium shares our findings on the genetic links between HS and inborn errors of ...

Therapies that unleash the immune system to fight tumors have greatly extended the lives of people with many types of cancer.

Kanazawa University and colleagues have developed a promising new approach to cancer treatment. By using tiny, naturally ...

A new study conducted by researchers from the Cancer Science Institute of Singapore (CSI Singapore) at the National ...

Patients with hereditary angioedema who switched from other drugs to donidalorsen for long-term prophylaxis experienced fewer attacks and improved disease control, according to a poster presented here ...